June 24, 2026 Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia
June 24, 2026 Prospect Floating Rate and Alternative Income Fund Announces a 14.96% Annualized Total Cash Common Shareholder Distribution Rate on Net Asset Value for June 2026
